National Cancer Registry

Definition	A cancer registry is defined as a location, be it an office or institution, where collection, storage, analysis and interpretation of data on cancer patients take place (Jenson et al, 1991).
Objectives	- To measure cancer incidence - To describe cancer by time, place, persons and disease - To provide a national database for further epidemiological research
Case definition	Target cases are: - Incident cases by year of diagnosis - Malignant tumors confirmed by histopathology and/or hematology findings - Cancers of all sites
Sources of data	Data are collected through two main channels: the capture system (passive reporting) and the recapture system (active reporting). 1) The capture system: The capture system is based on physician’s routine reporting of cancer cases. Physician’s complete and send forms: - Directly from their clinic; or - Indirectly through the MOPH Drug Dispensing Center (DDC), where anti-cancer drugs are distributed to eligible patients 2) The recapture system: The recapture system is based on gathering information directly from histopathological and hematological laboratories. Data are collected in various ways, using hard or soft copies, or using database file or individual laboratory results depending on laboratories resources. This process is active since the NCR personnel actually contact the sites to obtain the necessary data. The recapture system validates and complements the capture approach.
Medical coding	The coding of cancer primary sites and cancer morphology is done using International Classification of Diseases for Oncology, third edition (ICD-O-3). The code includes information on the topography (primary site), the histology, the behavior and the grade of the tumor. The structure is C##.# M####/##, where: - C##.# specifies the primary site - M#### specifies the histology - /## specifies the behavior and the grade of the tumor
Reporting form	NCR reporting form

ATC	Name	B/G	Ingredients	Dosage	Form	Price
R03AK06	SEROFLO-S 125	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 125mcg/inhalation		Inhalation suspension	1,212,146 L.L
R03AK06	SEROFLO 250	G	Salmeterol (xinafoate) - 50mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,580,359 L.L
R07AA	SURFACTANTE B RICHET	G	Pulmonary surfactant, bovine - 200mg/8ml	200mg/8ml	Suspension	26,568,472 L.L
R03AK06	SEROFLO-S 250	G	Salmeterol (xinafoate) - 25mcg/inhalation, Fluticasone propionate - 250mcg/inhalation		Inhalation suspension	1,725,494 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	18,264,981 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	17,079,643 L.L
N02BE01	SICADOL	G	Paracetamol - 1000mg	1000mg	Tablet	423,310 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 12.5mg	12.5mg	Capsule	36,042,560 L.L
N02BE01	SULDEX B	G	Paracetamol - 150mg	150mg	Suppository	117,746 L.L
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 12.5mg	12.5mg	Capsule, hard	38,073,237 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 25mg	25mg	Capsule	64,804,314 L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Tablet, gastroresistant	2,013,076 L.L
A02BC01	SANAMIDOL	G	Omeprazole - 20mg	20mg	Capsule	456,906 L.L
L01EX01	SOVIDEX	G	Sunitinib maleate - 50mg	50mg	Capsule	118,623,323 L.L
N02BE01	SULDEX 250	G	Paracetamol - 250mg	250mg	Suppository	127,985 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	593,850 L.L
L01EX01	SUNITINIB AQVIDA	G	Sunitinib maleate - 50mg	50mg	Capsule, hard	125,308,072 L.L
A02BC01	STOMAZOLE	G	Omeprazole - 20mg	20mg	Capsule	15,757,784 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1g	1g	Tablet, gastroresistant	4,073,187 L.L
N02BE01	SULDEX A	G	Paracetamol - 600mg	600mg	Suppository	200,936 L.L
L04AA27	SCLEMOD	G	Fingolimod Hydrochloride - 0.5mg	0.5mg	Capsule	L.L
A07EC02	SALCROZINE	G	Mesalazine - 500mg	500mg	Suppository	576,508 L.L
N02BE01	SULDEX 125	G	Paracetamol - 125mg	125mg	Suppository	110,067 L.L
A07EC02	SALCROZINE	G	Mesalazine - 1000mg	1000mg	Suppository	2,306,034 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	158,587 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	171,228 L.L
B05CX01	SERUFLEX DEXTROSE 5% INJECTION, USP	G	Glucose - 5%	5%	Injectable solution	193,062 L.L
C05AA01	SEDIPROCT	G	Hydrocortisone - 500mg, Cinchocaine HCl - 500mg		Cream	290,270 L.L
B05CX01	SOLUFLEX DEXTROSE 5% INJECTION USP	G	Glucose - 5%	5%	Injectable solution	186,167 L.L

National Cancer Registry (NCR)